João D Dias1, Carlos G Lopez-Espina, Jeffrey Ippolito, L Hsiuyin Hsiao, Fowzia Zaman, Adina A Muresan, Scott G Thomas, Mark Walsh, Alexander Joseph Jones, Anne Grisoli, Brian C Thurston, Ramin Artang, Kevin P Bilden, Jan Hartmann, Hardean E Achneck. 1. From the Haemonetics S.A. (J.D.D.), Signy, Switzerland; Haemonetics Corporation (C.G.L-E., F.Z., A.A.M.), Rosemont, Illinois; Haemonetics Corporation (J.I., L.H.H., J.H., H.E.A.), Braintree, Massachusetts; Memorial Hospital of South Bend (S.G.T., M.W.), Trauma Center, South Bend, Indiana; Indiana University School of Medicine (M.W., A.J.J., A.G.), South Bend, Indiana; Spartanburg Regional Medical Center, General Surgery, Trauma (B.C.T.), Spartanburg, South Carolina; Essentia Health St. Mary's Heart and Vascular Center (R.A.), Cardiology, Duluth, Minnesota; and Inova Heart and Vascular Institute (K.P.B.), Inova Center for Thrombosis Research and Drug Development, Falls Church, Virginia.
Abstract
BACKGROUND: The trauma patient on direct oral anticoagulant (DOAC) therapy preinjury presents a challenge in trauma and acute care surgery. Our understanding of these patients is extrapolated from vitamin K antagonists. However, DOACs have different mechanisms of action, effects on laboratory coagulation assays, and reversal strategies. Rapid identification of DOACs in the blood will allow timely reversal of factor Xa inhibitors and direct thrombin inhibitors when necessary. The present study evaluated viscoelastic testing to detect and classify DOACs in patient blood samples. METHODS: This observational, prospective, open-label, multicenter study used point-of-care viscoelastic testing to analyze blood samples taken from patients with and without DOAC treatment, and healthy volunteers. Antifactor Xa and direct thrombin inhibition (DTI) assays were used to establish reference ranges for viscoelastic testing parameters on the TEG 6s system. These ranges were applied to produce a DOAC identification algorithm for patient blood samples. Internal consistency of the measurements, as well as algorithm sensitivity and specificity, was evaluated. RESULTS: Using the TEG 6s system, the R parameter reference range was 0.6 minutes to 1.5 minutes for the Antifactor Xa assay and 1.6 minutes to 2.5 minutes for the DTI assay. Our identification algorithm using these ranges for 2.5 minutes or less has sensitives of 98.3% and 100% for factor Xa inhibitor and direct thrombin inhibitor detection, respectively. Specificity was 100%. Both classes of DOAC were detectable, even when samples were collected during the "trough" between doses of medication. CONCLUSION: Point-of-care viscoelastic testing with TEG 6s can detect and classify DOACs with high sensitivity and specificity. This tool can be used to better determine the need for reversal in trauma and acute care surgery patients and guide optimal surgical timing in the acute setting. LEVEL OF EVIDENCE: Prognostic and epidemiological study, level II.
BACKGROUND: The traumapatient on direct oral anticoagulant (DOAC) therapy preinjury presents a challenge in trauma and acute care surgery. Our understanding of these patients is extrapolated from vitamin K antagonists. However, DOACs have different mechanisms of action, effects on laboratory coagulation assays, and reversal strategies. Rapid identification of DOACs in the blood will allow timely reversal of factor Xa inhibitors and direct thrombin inhibitors when necessary. The present study evaluated viscoelastic testing to detect and classify DOACs in patient blood samples. METHODS: This observational, prospective, open-label, multicenter study used point-of-care viscoelastic testing to analyze blood samples taken from patients with and without DOAC treatment, and healthy volunteers. Antifactor Xa and direct thrombin inhibition (DTI) assays were used to establish reference ranges for viscoelastic testing parameters on the TEG 6s system. These ranges were applied to produce a DOAC identification algorithm for patient blood samples. Internal consistency of the measurements, as well as algorithm sensitivity and specificity, was evaluated. RESULTS: Using the TEG 6s system, the R parameter reference range was 0.6 minutes to 1.5 minutes for the Antifactor Xa assay and 1.6 minutes to 2.5 minutes for the DTI assay. Our identification algorithm using these ranges for 2.5 minutes or less has sensitives of 98.3% and 100% for factor Xa inhibitor and direct thrombin inhibitor detection, respectively. Specificity was 100%. Both classes of DOAC were detectable, even when samples were collected during the "trough" between doses of medication. CONCLUSION: Point-of-care viscoelastic testing with TEG 6s can detect and classify DOACs with high sensitivity and specificity. This tool can be used to better determine the need for reversal in trauma and acute care surgery patients and guide optimal surgical timing in the acute setting. LEVEL OF EVIDENCE: Prognostic and epidemiological study, level II.
Authors: Sudha Jayaraman; Jonathan H DeAntonio; Stefan W Leichtle; Jinfeng Han; Loren Liebrecht; Daniel Contaifer; Caroline Young; Christopher Chou; Julia Staschen; David Doan; Naren Gajenthra Kumar; Luke Wolfe; Tammy Nguyen; Gregory Chenault; Rahul J Anand; Jonathan D Bennett; Paula Ferrada; Stephanie Goldberg; Levi D Procter; Edgar B Rodas; Alan P Rossi; James F Whelan; Ventaka Ramana Feeser; Michael J Vitto; Beth Broering; Sarah Hobgood; Martin Mangino; Michel Aboutanos; Lorin Bachmann; Dayanjan S Wijesinghe Journal: J Trauma Acute Care Surg Date: 2020-04 Impact factor: 3.697
Authors: Galit H Frydman; Felix Ellett; Elizabeth M Van Cott; Douglas Hayden; Maulik Majmudar; Charles R Vanderburg; Haley Dalzell; Divya L Padmanabhan; Nick Davis; Julianne Jorgensen; Mehmet Toner; James G Fox; Ronald G Tompkins Journal: Crit Care Explor Date: 2019-08-20
Authors: Ramin Artang; Joao D Dias; Mark Walsh; Kevin Bliden; Jorn D Nielsen; Maren Anderson; Brian C Thurston; Udaya S Tantry; Jan Hartmann; Paul A Gurbel Journal: TH Open Date: 2021-11-09
Authors: Oksana Volod; Connor M Bunch; Nuha Zackariya; Ernest E Moore; Hunter B Moore; Hau C Kwaan; Matthew D Neal; Mahmoud D Al-Fadhl; Shivani S Patel; Grant Wiarda; Hamid D Al-Fadhl; Max L McCoy; Anthony V Thomas; Scott G Thomas; Laura Gillespie; Rashid Z Khan; Mahmud Zamlut; Peter Kamphues; Dietmar Fries; Mark M Walsh Journal: J Clin Med Date: 2022-02-07 Impact factor: 4.241
Authors: Mathew K Marsee; Faisal S Shariff; Grant Wiarda; Patrick J Watson; Ali H Sualeh; Toby J Brenner; Max L McCoy; Hamid D Al-Fadhl; Alexander J Jones; Patrick K Davis; David Zimmer; Craig Folsom Journal: J Clin Med Date: 2022-02-20 Impact factor: 4.241
Authors: James H Lantry; Phillip Mason; Matthew G Logsdon; Connor M Bunch; Ethan E Peck; Ernest E Moore; Hunter B Moore; Matthew D Neal; Scott G Thomas; Rashid Z Khan; Laura Gillespie; Charles Florance; Josh Korzan; Fletcher R Preuss; Dan Mason; Tarek Saleh; Mathew K Marsee; Stefani Vande Lune; Qamarnisa Ayoub; Dietmar Fries; Mark M Walsh Journal: J Clin Med Date: 2022-01-12 Impact factor: 4.241